Data from the literature also suggest that the process of brain atrophy appears to be slowed down in patients treated with DMTs, including oral drugs such as the S1P modulators [31,32,33] teriflunomide [34] and dimethyl fumarate [35,36]. Here, MBTPS1 is linked to Brain atrophy.